10/6/2021, 6:20 PM (Source: TeleTrader)
more TeleTrader news

WHO approves first malaria vaccine

The World Health Organization (WHO) recommended on Wednesday GlaxoSmithKline PLC (GSK) and Walter Reed Army Institute of Research's (WRAIR) vaccine against malaria for use in children at risk.

WHO Director-General Dr. Tedros Adhanom Ghebreyesus described the event as "a historic moment" and "breakthrough for science." "Today's recommendation offers a glimmer of hope for the continent which shoulders the heaviest burden of the disease," WHO Regional Director for Africa Dr. Matshidiso Moeti commented, adding that more than 260,000 African children under the age of five die from malaria each year.

Back in 2019, the WHO's Strategic Advisory Group of Experts on Immunization (SAGE) and the Malaria Policy Advisory Committee (MPAC) recommended a pilot implementation of the treatment in Africa. The project was then launched in Malawi, Ghana, and Kenya. The medicine is now expected to be distributed throughout the continent by Gavi, the global health partnership that helps low-income countries gain access to immunization.

Baha Breaking News (BBN) / JR